Loading organizations...
Loading organizations...
AI models of human cells to design better cancer drugs.
Vevo Therapeutics has raised $42.0M across 2 funding rounds.
Vevo Therapeutics has raised $42.0M in total across 2 funding rounds.
Vevo Therapeutics has raised $42.0M in total across 2 funding rounds.
Vevo Therapeutics's investors include Sunil Dhaliwal, Krish Ramadurai, Civilization Ventures, Conviction, Databricks Ventures, General Catalyst, Wing Venture Capital, Deep Nishar, Gaurav Garg, AIX Ventures, Camford Capital, Ayman AlAbdallah.
Vevo Therapeutics has raised $42.0M across 2 funding rounds. Most recently, it raised $30.0M Other Equity in August 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 11, 2025 | $30.0M Other Equity | Sunil Dhaliwal | Krish Ramadurai, Civilization Ventures, Conviction, Databricks Ventures, General Catalyst, Wing Venture Capital |
| Dec 8, 2022 | $12.0M Seed | Deep Nishar, Gaurav Garg | AIX Ventures, Camford Capital, Ayman AlAbdallah |